| P50 | author | Kathy Ho Yen Shair | Q81398989 |
| | Nancy Raab-Traub | Q90483481 |
| P2860 | cites work | NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells | Q22254088 |
| | Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice | Q24524255 |
| | Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice | Q27345929 |
| | The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 |
| | ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus | Q28471803 |
| | Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme | Q29547201 |
| | EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas | Q30837949 |
| | Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling | Q33781678 |
| | Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression | Q33786551 |
| | Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway | Q33787396 |
| | Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. | Q33898010 |
| | Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation | Q34029669 |
| | Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis | Q34228703 |
| | Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development | Q34462049 |
| | The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease | Q34508618 |
| | Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro | Q34717880 |
| | An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking | Q35000168 |
| | Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 |
| | Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus | Q35848189 |
| | Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. | Q35943724 |
| | Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice | Q36327458 |
| | Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes | Q36646940 |
| | Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. | Q36890676 |
| | Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells | Q37093324 |
| | Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. | Q39585482 |
| | Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo | Q40274082 |
| | Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells | Q40326039 |
| | The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. | Q40471301 |
| | Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. | Q40895264 |
| | Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model | Q42564555 |
| | ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells | Q42638304 |
| | The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. | Q43808409 |
| | Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals | Q44664210 |
| | Epstein-Barr virus latent membrane protein 2A and autoimmunity | Q45405684 |
| | Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes | Q45424361 |
| | Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma | Q45605928 |
| | Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma | Q45722302 |
| | Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses | Q45746898 |
| | Expression of the Cytoplasmic Tail of LMP1 in Mice Induces Hyperactivation of B Lymphocytes and Disordered Lymphoid Architecture | Q57791640 |
| | LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice | Q81398990 |
| P433 | issue | 5 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P577 | publication date | 2012-09-18 | |
| P1433 | published in | mBio | Q15817061 |
| P1476 | title | Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma | |
| P478 | volume | 3 | |